Golub Capital BDC, inc (GBDC) Q4 2021 Earnings Call Transcript
GBDC earnings call for the period ending September 30, 2021.
Stay updated with breaking news from Events Presentations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GBDC earnings call for the period ending September 30, 2021.
Preliminary data showed that isaralgagene civaparvovec, or ST-920, was generally well tolerated - All four patients in the first two dose cohorts exhibited above normal a-Gal A activity, which was maintained
The company shared third quarter and year-to-date 2021 results through a Shareholder Letter and Webcast Wallbox N.V. (NYSE: WBX), a leading provider of electric vehicle (EV) charging and energy
TYME Technologies, Inc. (Nasdaq: TYME) (the Company or TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs), today announced that Richie Cunningham, Chief Executive
ADC Therapeutics SA: ADC Therapeutics to Present at Jefferies Virtual Healthcare Conference ADC Therapeutics SA (NYSE: ADCT), a commercial-stage biotechnology company leading the development of novel antibody drug conjugates (ADCs) to treat hematological malignancies and solid tumors, announced today that Chris Martin, Chief Executive Officer, will present at the Jefferies Virtual Healthcare Conference on Thursday, June 3, 2021, at 8:30 a.m. ET. A live webcast of the presentation will be available via the Events Presentations page in the Investors section of ADC Therapeutics' website, ir.adct...